Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 2Completed 1

Sponsor Class

OTHER 2UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Rectal Neoplasms 8Colorectal Neoplasms 8Colonic Neoplasms 4Stomach Neoplasms 3Thrombocytopenia 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mesothelioma, Malignant 1Inoperable Esophageal Cancer Stage I-III 1Hepatecellular Carcinoma 1Fruquintinib 1Esophageal Squamous Cell Carcinoma 1Advanced Metastatic Colorectal Cancer 1Advanced Gastric Cancer 1Advanced Colorectal Carcinoma 1Advanced Colorectal Cancer 1

Interventions

Oxaliplatin 166Capecitabine 112Fluorouracil 95Docetaxel 85Cisplatin 84S 1 (combination) 83Leucovorin 64Paclitaxel 58Irinotecan 56pembrolizumab 36sintilimab 34Trastuzumab 34apatinib 30Bevacizumab 21Surgical Procedures, Operative 19Radiotherapy 19titanium silicide 17camrelizumab 17Nivolumab 17Ramucirumab 16Drug Therapy 15Hyperthermic Intraperitoneal Chemotherapy 14Folfox protocol 14Epirubicin 14tislelizumab 13Neoadjuvant Therapy 12Cetuximab 12XELOX 10Tegafur 10Carboplatin 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Stomach Neoplasms × raltitrexed × Clear all
NCT03083613 2021-02-01

Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma

ChineseAMS

Phase 2 Completed
41 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03392103 2018-01-05

Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical Resection

Zhongnan Hospital

Phase 2 Unknown
48 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01836120 2013-04-19

A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer

Hebei Tumor Hospital

Phase 2 Unknown
100 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡